Roferon-A 6 mio i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
Interferon alfa-2a, rekombinantni
General information
Drug nameRoferon-A 6 mio i.e./0,5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi
Medicine nameInterferon alfa-2a, rekombinantni
National drug code3000005
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug group—
OriginatorNo
Orphan drugNo
Marketing authorization
Procedure typePrenehanje veljavnosti dovoljenja za promet
No. and date of decision/certificate103-52/2016-3, 22. 11. 2016
Authorization validity date22. 11. 2016
Marketing end date23. 5. 2018
Application type—
Authorization/certificate holderROCHE d.o.o.
Drug safety monitoring
Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No
ATC codes
Route of administration
Route of administration name
Intravenska/subkutana uporaba
Settlement data for compulsory health insurance billing
Substitute medicine
Preparation—
Valid from – to—
Clinical use data
Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo
Shortage actions
Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo
Drug status
Announced permanent cessation of marketing of the medicinal product.
Last drug update date:9. 7. 2026